Literature DB >> 22889976

Breast cancer screening: the questions answered.

Philippe Autier1, Laura J Esserman, Chris I Flowers, Nehmat Houssami.   

Abstract

Early detection of cancer has long been thought to be the first step towards eradicating the mortality associated with the disease. National screening programmes for breast cancer have been implemented in many countries. However, there is controversy regarding the efficacy and optimal methods of screening, which is regularly discussed in articles, at conferences and is apparent in conflicting guidelines. In this article, Nature Reviews Clinical Oncology asks four experts their opinions on some of the pressing questions associated with breast cancer screening.

Entities:  

Mesh:

Year:  2012        PMID: 22889976     DOI: 10.1038/nrclinonc.2012.126

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


  43 in total

1.  Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study.

Authors:  Rebecca A Hubbard; Karla Kerlikowske; Chris I Flowers; Bonnie C Yankaskas; Weiwei Zhu; Diana L Miglioretti
Journal:  Ann Intern Med       Date:  2011-10-18       Impact factor: 25.391

2.  Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.

Authors:  Mette Kalager; Hans-Olov Adami; Michael Bretthauer; Rulla M Tamimi
Journal:  Ann Intern Med       Date:  2012-04-03       Impact factor: 25.391

3.  Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes.

Authors:  E Lăără; N E Day; M Hakama
Journal:  Lancet       Date:  1987-05-30       Impact factor: 79.321

4.  Biologic markers determine both the risk and the timing of recurrence in breast cancer.

Authors:  Laura J Esserman; Dan H Moore; Pamela J Tsing; Philip W Chu; Christina Yau; Elissa Ozanne; Robert E Chung; Vickram J Tandon; John W Park; Frederick L Baehner; Stig Kreps; Andrew N J Tutt; Cheryl E Gillett; Christopher C Benz
Journal:  Breast Cancer Res Treat       Date:  2011-05-20       Impact factor: 4.872

Review 5.  Impact of mammographic screening on the detection of good and poor prognosis breast cancers.

Authors:  Laura J Esserman; Yiwey Shieh; Emiel J T Rutgers; Michael Knauer; Valesca P Retèl; Stella Mook; Annuska M Glas; Dan H Moore; Sabine Linn; Flora E van Leeuwen; Laura J van 't Veer
Journal:  Breast Cancer Res Treat       Date:  2011-09-04       Impact factor: 4.872

6.  Mammography screening: a new estimate of number needed to screen to prevent one breast cancer death.

Authors:  R Edward Hendrick; Mark A Helvie
Journal:  AJR Am J Roentgenol       Date:  2012-03       Impact factor: 3.959

Review 7.  Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer.

Authors:  Ellen Warner; Hans Messersmith; Petrina Causer; Andrea Eisen; Rene Shumak; Donald Plewes
Journal:  Ann Intern Med       Date:  2008-05-06       Impact factor: 25.391

8.  Informed choice in mammography screening: a randomized trial of a decision aid for 70-year-old women.

Authors:  Erin Mathieu; Alexandra Barratt; Heather M Davey; Kevin McGeechan; Kirsten Howard; Nehmat Houssami
Journal:  Arch Intern Med       Date:  2007-10-22

Review 9.  Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.

Authors:  Beth A Virnig; Todd M Tuttle; Tatyana Shamliyan; Robert L Kane
Journal:  J Natl Cancer Inst       Date:  2010-01-13       Impact factor: 13.506

10.  Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database.

Authors:  Philippe Autier; Mathieu Boniol; Anna Gavin; Lars J Vatten
Journal:  BMJ       Date:  2011-07-28
View more
  6 in total

1.  Mammography screening and women with symptomatic breast cancer.

Authors:  Philippe Autier
Journal:  Nat Rev Clin Oncol       Date:  2013-07-23       Impact factor: 66.675

2.  Earlier diagnosis of breast cancer outside of a screening programme.

Authors:  Chris I Flowers
Journal:  Nat Rev Clin Oncol       Date:  2013-07-23       Impact factor: 66.675

3.  Addressing overdiagnosis and overtreatment in cancer: a prescription for change.

Authors:  Laura J Esserman; Ian M Thompson; Brian Reid; Peter Nelson; David F Ransohoff; H Gilbert Welch; Shelley Hwang; Donald A Berry; Kenneth W Kinzler; William C Black; Mina Bissell; Howard Parnes; Sudhir Srivastava
Journal:  Lancet Oncol       Date:  2014-05       Impact factor: 41.316

4.  Earlier diagnosis of breast cancer: focusing on symptomatic women.

Authors:  Georgios Lyratzopoulos; Gary Abel
Journal:  Nat Rev Clin Oncol       Date:  2013-07-23       Impact factor: 66.675

5.  Framing overdiagnosis in breast screening: a qualitative study with Australian experts.

Authors:  Lisa M Parker; Lucie Rychetnik; Stacy Carter
Journal:  BMC Cancer       Date:  2015-08-28       Impact factor: 4.430

6.  Using an informed consent in mammography screening: a randomized trial.

Authors:  José M Baena-Cañada; Petra Rosado-Varela; Inmaculada Expósito-Álvarez; Macarena González-Guerrero; Juan Nieto-Vera; Encarnación Benítez-Rodríguez
Journal:  Cancer Med       Date:  2015-09-17       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.